Literature DB >> 18256784

Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.

Xiao Li1, Lingyun Wu2, Shaoxu Ying2, Chunkang Chang2, Quan Pu2.   

Abstract

The aim of this paper was to investigate whether the morphological dysplastic cells in myelodysplastic syndromes (MDS) marrows derived from abnormal chromosomal clone. Fluorescence in situ hybridization was used in combination with immunochemistry/immuno-magnetic bead sorting to investigate the penetration of chromosomal abnormalities into dysplastic hematopoietic cells in MDS patients with documented chromosome abnormalities in the bone marrow at diagnosis. Typical granulocyte dysplasia was defined as granulocytes with bilobed pseudo Pelger-Huet anomaly, erythrocyte dysplasia as tri-nucleus or nuclear budding erythrocytes (21 patients were investigated, respectively) and megakaryocytes dysplasia as lymphocytic appearance megakaryocytes (14 patients were investigated). When data were analyzed as a whole, the mean percentage of clonal cells with typical dysplasis was always lower than clonal cell percentage in all nucleated cells no matter whether in granulocytes, erythrocytes or megakaryocytes. For each individual case, the situation was the same with just few exceptions. The chromosome ploidy of micro-megakaryocytes was obviously reduced when compared to reported normal megakaryocytes. Our research suggested that tri-lineage morphological dyshematopoiesis is secondum alteration not a specific feature (imagery) of the abnormal chromosomal clone in MDS.

Entities:  

Mesh:

Year:  2008        PMID: 18256784     DOI: 10.1007/s12185-008-0038-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow.

Authors:  H Baurmann; T F Schwarz; J Oertel; S Serke; M Roggendorf; D Huhn
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

Review 2.  Classification and morphologic features of the myelodysplastic syndromes.

Authors:  J E Goasguen; J M Bennett
Journal:  Semin Oncol       Date:  1992-02       Impact factor: 4.929

3.  Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy.

Authors:  K van Lom; A B Houtsmuller; W L van Putten; R M Slater; B Löwenberg
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

4.  Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).

Authors:  A Cantù Rajnoldi; S Fenu; G Kerndrup; E R van Wering; C M Niemeyer; I Baumann
Journal:  Ann Hematol       Date:  2005-04-19       Impact factor: 3.673

5.  Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.

Authors:  M Fontenay-Roupie; D Bouscary; M Guesnu; F Picard; J Melle; C Lacombe; S Gisselbrecht; P Mayeux; F Dreyfus
Journal:  Br J Haematol       Date:  1999-08       Impact factor: 6.998

6.  Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome.

Authors:  Xiao Li; C Eileen Bryant; H Joachim Deeg
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

7.  Balloon-like platelets in myelodysplastic syndromes--a feature of dysmegakaryopoiesis?

Authors:  S Widell; R Hast
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

8.  Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes.

Authors:  R Hast; I Nilsson; S Widell; A Ost
Journal:  Leuk Res       Date:  1989       Impact factor: 3.156

9.  What is ineffective erythropoiesis in myelodysplastic syndromes?

Authors:  D Bowen
Journal:  Leuk Lymphoma       Date:  1995-07

10.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.

Authors:  A Raza; S Gezer; S Mundle; X Z Gao; S Alvi; R Borok; S Rifkin; A Iftikhar; V Shetty; A Parcharidou
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

View more
  1 in total

1.  Severe generalized muscular atrophia, nerve optic atrophia, ear problem and disability with Pelger-Huet anomaly.

Authors:  Hassan Mahmoodi Nesheli; Naimeh Nakhjavani; Tahere Galini Moghaddam
Journal:  Caspian J Intern Med       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.